Paul Wang joined the Simons Foundation in 2016 as deputy director of Clinical Research Associates. He is a developmental-behavioral pediatrician with broad experience across academia, industry and the nonprofit/advocacy sector. He served on the faculty at Children’s Hospital of Philadelphia from 1995 to 2002, helping to care for children with autism and intellectual disabilities, especially those with genetic diagnoses. His research there focused on language and memory development in these populations.

From 2002 to 2008, Wang worked at Pfizer, leading clinical trials in neurologic and psychiatric disorders. He subsequently led the clinical development of arbaclofen for autism and for fragile X syndrome at Seaside Therapeutics. Prior to joining the Simons Foundation, Wang also worked as head of medical research at Autism Speaks and held leadership positions in the American Academy of Pediatrics and the Society for Developmental and Behavioral Pediatrics. He was one of the founding members of the Sub-board of Developmental-Behavioral Pediatrics of the American Board of Pediatrics.